LONDON and WASHINGTON, July 21, 2014 — In the July/August 2014 issue of Intellectual Property Magazine, Baker Botts partners Neil Coulson and Mark Whitaker discuss recent developments in the UK and the US regarding medical devices, and as it becomes harder for righstholders to control the flow of infringing medical products, they review developing case law on both sides of the Atlantic.
Throughout the article, they look at a recent decision in the UK relating to the applicability of supplementary protection certificates (SPCs), and the developing jurisdiction of the US International Trade Commission (US ITC), specifically as it relates to medical devices.
Coulson and Whitaker mention that in the US, “given that trading of medical technology has expanded into a worldwide network of importation and exportation, the sources of possible infringement have multiplied. They further stated, “The international nature of the industry has allowed competitors to import and export their products to new markets, making it difficult for rightsholders to control the flow of infringing products.”
To view the complete Intellectual Property Magazine article, please click here.
About Baker Botts L.L.P.
Baker Botts is an international law firm of approximately 700 lawyers practicing throughout a network of 15 offices around the globe. Based on our experience and knowledge of our clients’ industries, we are recognized as a leading firm in the energy, technology and life sciences sectors. Throughout our 174-year history, we have provided creative and effective legal solutions for our clients while demonstrating an unrelenting commitment to excellence. For more information, please visit BakerBotts.com.